Delota Corp. (CSE:NIC)
Canada · Delayed Price · Currency is CAD 0.0850
-0.0050 (-5.56%)
At close: Dec 5, 2025
Delota Revenue
In the fiscal year ending March 31, 2025, Delota had annual revenue of 39.91M CAD, down -0.72%. Delota had revenue of 8.67M in the quarter ending September 30, 2025, a decrease of -11.12%.
Revenue
39.91M
Revenue Growth
+9.58%
P/S Ratio
0.06
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.47M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 39.91M | -289.34K | -0.72% |
| Jan 31, 2025 | 40.20M | 6.13M | 18.00% |
| Jan 31, 2024 | 34.07M | 8.13M | 31.35% |
| Jan 31, 2023 | 25.94M | 8.25M | 46.66% |
| Jan 31, 2022 | 17.69M | 16.41M | 1,285.90% |
| Jan 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Trulieve Cannabis | 1.66B |
| Green Thumb Industries | 1.61B |
| Extendicare | 1.59B |
| WELL Health Technologies | 1.25B |
| Sienna Senior Living | 967.05M |
| Knight Therapeutics | 413.85M |